Trastuzumab is a HER2-targeted monoclonal antibody used to treat HER2-positive breast cancer and metastatic gastric cancer. It works by binding to HER2 receptors on cancer cells, blocking growth signals and slowing tumor progression.
Can cause cardiac toxicity — regular heart monitoring (every 3 months, up to 2–5 years post-treatment) is recommended. Not for use in patients under 18. Use effective contraception during and for 7 months after treatment. Not recommended during pregnancy or breastfeeding.
Manufactured under WHO-GMP standards with batch-level quality testing for HER2-binding efficacy and purity.
COA, COO, Free Sale Certificate, and MSDS provided per shipment. Available for bulk/export orders.
GDP-compliant cold chain export (2–8°C) to LATAM, Africa, Middle East, and Asia-Pacific markets.
Supports hospital procurement, distributor partnerships, and named-patient access programs globally.
What is Trastuzumab used for?
Treats HER2-positive breast cancer and metastatic gastric cancer.
Get Trastuzumab price — how do I request a quote?
Send strength and destination country for a verified export quote within 24 hours.
Who is a reliable Trastuzumab exporter from India?
WHO-GMP certified supply with full documentation and cold-chain logistics.
Does it cause heart problems?
Yes, cardiac monitoring is recommended throughout and after treatment.
Can it be used during pregnancy?
No, it may harm the developing baby — contraception is advised during treatment.
